Publication | Open Access
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
312
Citations
32
References
2015
Year
Everolimus plus letrozole results in a high CBR and RR in patients with recurrent EC. Further development of this combination in recurrent endometrioid EC is under way.
| Year | Citations | |
|---|---|---|
Page 1
Page 1